Tag: Metastatic
Merck Announces FDA Breakthrough Therapy Designation for Investigational Therapy Tepotinib in Patients with Metastatic NSCLC with METex14 Skippin

Merck Announces FDA Breakthrough Therapy Designation for Investigational Therapy Tepotinib in Patients with Metastatic NSCLC with METex14 Skippin

- Investigational oral MET inhibitor has previously received SAKIGAKE 'fast-track' regulatory designation in Japan - MET exon 14 skipping alterations and MET amplifications ...

Lees verder
European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma

European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma

DARMSTADT, Germany, and NEW YORK, USA, September 21, 2017 /PRNewswire/ -- Not intended for US, Canadian and UK-based media     - First approved immunotherapy for ...

Lees verder
EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma

EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma

DARMSTADT, Germany and NEW YORK, July 21, 2017 /PRNewswire/ -- Not intended for US, Canadian and UK-based media   - If approved, ...

Lees verder
BizPress.nl